1
|
Nieto I, Mayo X, Davies L, Reece L, Strafford BW, Jimenez A. Consensus on a social return on investment model of physical activity and sport: a Delphi study protocol. Front Sports Act Living 2024; 6:1334805. [PMID: 38645726 PMCID: PMC11026584 DOI: 10.3389/fspor.2024.1334805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Accepted: 03/21/2024] [Indexed: 04/23/2024] Open
Abstract
Background Physical activity and sport (PAS) have been related to many health outcomes and social benefits. The main aim of this research is to build a Social Return on Investment (SROI) model of PAS based on experts' opinion to clarify the domains of impact and how to measure and value them. Methods and analysis A Delphi method will be employed with a systematic review on the SROI framework applied to PAS and initial interviews with experts informing the design of the Delphi survey statements. Three iterative rounds of communication with the expert panel will be carried out. Participants will indicate their level of agreement with each statement on a five-point Likert scale. During the second and third iterative rounds, experts will reappraise the statements and will be provided with a summary of the group responses from the panel. A statement will have reached consensus if ≥70% of the panel agree/strongly agree or disagree/strongly disagree after round 3. Finally, group meetings (3-4 experts) will be conducted to ask about the measurement and valuation methods for each domain. Discussion The final goal of this project will result in the design of a toolkit for organizations, professionals, and policymakers on how to measure the social benefits of PAS.
Collapse
Affiliation(s)
- I. Nieto
- Sports Science Research Centre, King Juan Carlos University, Madrid, Spain
- THiNKactive, EuropeActive Research Centre, Brussels, Belgium
| | - X. Mayo
- Sports Science Research Centre, King Juan Carlos University, Madrid, Spain
- THiNKactive, EuropeActive Research Centre, Brussels, Belgium
| | - L. Davies
- Sport Policy Unit and Institute of Sport, Manchester Metropolitan University, Manchester, England
| | - L. Reece
- Sport and Community Capability, Australian Sport Commission, Canberra, ACT, Australia
| | - B. W. Strafford
- Sport and Physical Activity Research Centre (SPARC) and Academy of Sport and Physical Activity (ASPA), Sheffield Hallam University, Sheffield, England
| | - A. Jimenez
- Sports Science Research Centre, King Juan Carlos University, Madrid, Spain
- THiNKactive, EuropeActive Research Centre, Brussels, Belgium
| |
Collapse
|
2
|
Iglesias SL, Nieto I, López P, Almada A, Pioli I, Astore F, Rodríguez Urmenyi C, Allende BL. [Translated article] Pericapsular nerves block (PENG) is an effective and safe alternative for postoperative pain management after primary total hip arthroplasty: A randomised clinical trial. Rev Esp Cir Ortop Traumatol (Engl Ed) 2023; 67:T226-T232. [PMID: 36863525 DOI: 10.1016/j.recot.2023.02.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Accepted: 12/13/2022] [Indexed: 03/04/2023] Open
Abstract
BACKGROUND Postoperative pain after total hip arthroplasty can affect postoperative rehabilitation and delay hospital discharge. The objective of this study is to compare pericapsular nerves group (PENG) block with pericapsular infiltration (PAI) and plexus nerve block (PNB) for postoperative pain management, response to physical therapy, opioid consumption, and length of hospital stay after a primary total hip arthroplasty. METHODS Randomised clinical trial of parallel and blinded groups was performed. Sixty patients who underwent elective THA between December 2018 and July 2020 were randomised into the different groups (PENG, PAI and PNB). The visual analogue scale was used to assess pain; and motor function was measured with the Bromage scale. We also record opioid usage, length of hospital stay, and related medical complications. RESULTS Pain level at discharge was similar in all groups. Hospital stay was 1 day shorter in the PENG group (p<0.001) and they also had lower opioid consumption (p=0.044). Optimal motor recovery was similar in the groups (p=0.678). Pain control when performing physical therapy was better in the PENG group (p<0.0001). CONCLUSIONS PENG block is an effective and safe alternative for patients undergoing THA as it reduces opioid consumption and hospital stay compared to other analgesic methods.
Collapse
Affiliation(s)
- S L Iglesias
- Instituto Allende, Cirugía Reconstructiva de los Miembros, Servicio de Artroplastia y Trauma del Miembro Inferior, Sanatorio Allende, Córdoba, Argentina.
| | - I Nieto
- Instituto Allende, Cirugía Reconstructiva de los Miembros, Servicio de Artroplastia y Trauma del Miembro Inferior, Sanatorio Allende, Córdoba, Argentina
| | - P López
- Instituto Allende, Cirugía Reconstructiva de los Miembros, Servicio de Artroplastia y Trauma del Miembro Inferior, Sanatorio Allende, Córdoba, Argentina
| | - A Almada
- Instituto Allende, Cirugía Reconstructiva de los Miembros, Servicio de Artroplastia y Trauma del Miembro Inferior, Sanatorio Allende, Córdoba, Argentina
| | - I Pioli
- Instituto Allende, Cirugía Reconstructiva de los Miembros, Servicio de Artroplastia y Trauma del Miembro Inferior, Sanatorio Allende, Córdoba, Argentina
| | - F Astore
- Servicio de Analgesia y Anestesia, Sanatorio Allende, Córdoba, Argentina
| | | | - B L Allende
- Instituto Allende, Cirugía Reconstructiva de los Miembros, Servicio de Artroplastia y Trauma del Miembro Inferior, Sanatorio Allende, Córdoba, Argentina
| |
Collapse
|
3
|
Iglesias SL, Nieto I, López P, Almada A, Pioli I, Astore F, Rodríguez Urmenyi C, Allende BL. Pericapsular nerves block (PENG) is an effective and safe alternative for postoperative pain management after primary total hip arthroplasty: A randomized clinical trial. Rev Esp Cir Ortop Traumatol (Engl Ed) 2022; 67:226-232. [PMID: 36529424 DOI: 10.1016/j.recot.2022.12.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Revised: 12/07/2022] [Accepted: 12/13/2022] [Indexed: 12/23/2022] Open
Abstract
BACKGROUND Postoperative pain after total hip arthroplasty can affect postoperative rehabilitation and delay hospital discharge. The objective of this study is to compare pericapsular nerves group (PENG) block with pericapsular infiltration (PAI) and plexus nerve block (PNB) for postoperative pain management, response to physical therapy, opioid consumption, and length of hospital stay after a primary total hip arthroplasty. METHODS Randomized clinical trial of parallel and blinded groups was performed. Sixty patients who underwent elective THA between December 2018 and July 2020 were randomized into the different groups (PENG, PAI and PNB). The visual analog scale was used to assess pain; and motor function was measured with the Bromage scale. We also record opioid usage, length of hospital stay, and related medical complications. RESULTS Pain level at discharge was similar in all groups. Hospital stay was 1 day shorter in the PENG group (p<0.001) and they also had lower opioid consumption (p=0.044). Optimal motor recovery was similar in the groups (p=0.678). Pain control when performing physical therapy was better in the PENG group (p<0.0001). CONCLUSIONS PENG block is an effective and safe alternative for patients undergoing THA as it reduces opioid consumption and hospital stay compared to other analgesic methods.
Collapse
Affiliation(s)
- S L Iglesias
- Instituto Allende, Cirugía Reconstructiva de los Miembros, Servicio de Artroplastia y Trauma del Miembro Inferior, Sanatorio Allende, Córdoba, Argentina.
| | - I Nieto
- Instituto Allende, Cirugía Reconstructiva de los Miembros, Servicio de Artroplastia y Trauma del Miembro Inferior, Sanatorio Allende, Córdoba, Argentina
| | - P López
- Instituto Allende, Cirugía Reconstructiva de los Miembros, Servicio de Artroplastia y Trauma del Miembro Inferior, Sanatorio Allende, Córdoba, Argentina
| | - A Almada
- Instituto Allende, Cirugía Reconstructiva de los Miembros, Servicio de Artroplastia y Trauma del Miembro Inferior, Sanatorio Allende, Córdoba, Argentina
| | - I Pioli
- Instituto Allende, Cirugía Reconstructiva de los Miembros, Servicio de Artroplastia y Trauma del Miembro Inferior, Sanatorio Allende, Córdoba, Argentina
| | - F Astore
- Servicio de Analgesia y Anestesia, Sanatorio Allende, Córdoba, Argentina
| | | | - B L Allende
- Instituto Allende, Cirugía Reconstructiva de los Miembros, Servicio de Artroplastia y Trauma del Miembro Inferior, Sanatorio Allende, Córdoba, Argentina
| |
Collapse
|
4
|
Zangri RM, Andreu CI, Nieto I, González AM, Vázquez C. Efficacy of mindfulness to regulate induced emotions in the laboratory: A systematic review and meta-analysis of self-report and biobehavioral measures. Neurosci Biobehav Rev 2022; 143:104957. [DOI: 10.1016/j.neubiorev.2022.104957] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2022] [Revised: 10/06/2022] [Accepted: 11/07/2022] [Indexed: 11/10/2022]
|
5
|
Nieto I, Koster EHW, Everaert J. The Role of Emotional Memory in Reappraising Negative Self-referent Thoughts. Cogn Ther Res 2021. [DOI: 10.1007/s10608-021-10216-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
6
|
Nieto I, Vazquez C. Disentangling the mediating role of modifying interpretation bias on emotional distress using a novel cognitive bias modification program. J Anxiety Disord 2021; 83:102459. [PMID: 34358756 DOI: 10.1016/j.janxdis.2021.102459] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/01/2021] [Revised: 07/12/2021] [Accepted: 07/26/2021] [Indexed: 11/26/2022]
Abstract
BACKGROUND Negative interpretation bias is a potential risk factor for emotional disorders. In this study, we tested a clinically inspired 4-session online Cognitive Bias Modification-Interpretation (CBM-IClin) program to modify negative interpretation biases. METHODS We randomized one hundred and twenty-one volunteer young adults (Mean age = 21.6 years, SD = 3.5; 85 % women) with varying levels of emotional distress to either an experimental or waitlist control group. Mediation analyses were used to disentangle the associations between the intervention, changes in interpretation biases (assessed by both a self-report and an experimental task), and changes in measures of cognitive vulnerability and symptoms of depression and anxiety. RESULTS The results showed that the CBM-IClin could change negative interpretation biases. Also, it had a direct effect on the change in negative memory bias, an indirect effect on the change in depression symptoms via the change in interpretation bias, and both direct and indirect effects on the change in self-reported dysfunctional attitudes. LIMITATIONS The study included a non-clinical sample of participants and it did not control for some potential confounding factors (e.g., attentional disorders). Furthermore, participants' engagement during the sessions at home was not supervised. CONCLUSIONS The CBM-IClin is a potential tool to prevent and intervene in emotional disorders in young adults and could complement other traditional CBM procedures or clinical interventions.
Collapse
Affiliation(s)
- Inés Nieto
- Department of Clinical Psychology, School of Psychology, Complutense University of Madrid, Spain.
| | - Carmelo Vazquez
- Department of Clinical Psychology, School of Psychology, Complutense University of Madrid, Spain
| |
Collapse
|
7
|
Nieto I, Vazquez C. 'Relearning how to think': A brief online intervention to modify biased interpretations in emotional disorders-study protocol for a randomised controlled trial. Trials 2021; 22:510. [PMID: 34332616 PMCID: PMC8325786 DOI: 10.1186/s13063-021-05459-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2020] [Accepted: 07/15/2021] [Indexed: 11/18/2022] Open
Abstract
Background Cognitive biases play an important role in the development and maintenance of emotional disorders, such as depression and anxiety. Novel procedures, known as Cognitive Bias Modification (CBM), aim to reduce these dysfunctional information processing modes. This study develops a brief clinically based online intervention programme to modify biased interpretations in depression and anxiety (CBM-IClin), overcoming some methodological issues that have been addressed in previous literature. Methods Volunteer participants will be recruited via social media and posters at the university. They will be randomly assigned to an experimental group or a waiting list control group. Both groups will complete two assessment sessions (before and after the intervention) consisting of questionnaires measuring cognitive and emotional variables as well as experimental tasks measuring cognitive biases (i.e. attention, memory, and interpretation). After the first assessment session, only participants in the experimental group will receive a link to follow the four CBM-IClin sessions at home. All participants will receive, via email, follow-up questionnaires 2 weeks and 3 months after the second assessment. Discussion This study will test the 'Relearning how to think', an online programme potentially beneficial to modify cognitive biases in emotional disorders. Several limitations of previous CBM procedures are addressed, and the impact of the programme both on objective cognitive bias tasks and clinical symptoms will be explored. Trial registration ClinicalTrials.gov NCT03987477. Prospectively registered on June 17, 2019
Collapse
Affiliation(s)
- Inés Nieto
- Department of Clinical Psychology, School of Psychology, Complutense University of Madrid, 28223, Madrid, Spain.
| | - Carmelo Vazquez
- Department of Clinical Psychology, School of Psychology, Complutense University of Madrid, 28223, Madrid, Spain
| |
Collapse
|
8
|
Nieto I, Robles E, Vazquez C. Self-reported cognitive biases in depression: A meta-analysis. Clin Psychol Rev 2020; 82:101934. [DOI: 10.1016/j.cpr.2020.101934] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2020] [Revised: 09/18/2020] [Accepted: 10/13/2020] [Indexed: 12/12/2022]
|
9
|
Gonzalez-Pose A, Garcia-Perez A, Gonzalez-Rodriguez M, Lopez Medina A, Mirete Bachiller S, Ochagavia V, Nieto I, Salvador F, Muñoz Garzón V. PO-1816: Impact of radiotherapy in immunological parameters in brain metastases by SRS. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)01834-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
10
|
Kowtha B, Byrd L, Nieto I, Chase M, Cunningham P, Rogers S. HRSA's Opioid and Oral Health Workforce Programs. J Acad Nutr Diet 2020. [DOI: 10.1016/j.jand.2020.06.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
11
|
Nieto I, Navas JF, Vázquez C. The quality of research on mental health related to the COVID-19 pandemic: A note of caution after a systematic review. Brain Behav Immun Health 2020; 7:100123. [PMID: 32835299 PMCID: PMC7395946 DOI: 10.1016/j.bbih.2020.100123] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2020] [Revised: 07/26/2020] [Accepted: 07/28/2020] [Indexed: 12/02/2022] Open
Abstract
Background and aims SARS-CoV-2 pandemic has spurred scientific production in diverse fields of knowledge, including mental health. Yet, the quality of current research may be challenged by the urgent need to provide immediate results to understand and alleviate the consequences of the pandemic. This study aims to examine compliance with basic methodological quality criteria and open scientific research practices on the mental health effects of the COVID-19 pandemic. Method and results Twenty-eight studies were identified through a systematic search. Most of them met the requirements related to reporting key methodological and statistical information. However, the widespread use of convenience samples and the lack of a priori power analysis, coupled with low compliance with open science recommendations, such as pre-registration of studies and availability of databases, raise concerns about the validity, generalisability, and reproducibility of the findings. Conclusions While the importance of offering rapid evidence-based responses to mitigate mental health problems stemming from the COVID-19 pandemic is undeniable, it should not be done at the expense of sacrificing scientific rigor. The results of this study may stimulate researchers and funding agencies to try to orchestrate efforts and resources and follow standard codes of good scientific practice. The quality of mental health research related to the COVID-19 pandemic may need to be revised. Main quality problems affect the validity and generalisability of findings. Open science practices are hardly followed in the literature examined.
Collapse
Affiliation(s)
- Inés Nieto
- Department of Clinical Psychology, Complutense University of Madrid, Spain
| | - Juan F Navas
- Department of Clinical Psychology, Complutense University of Madrid, Spain
| | - Carmelo Vázquez
- Department of Clinical Psychology, Complutense University of Madrid, Spain
| |
Collapse
|
12
|
Samalin L, Yrondi A, Charpeaud T, Genty JB, Blanc O, Sauvaget A, Stéphan F, Walter M, Bennabi D, Bulteau S, Haesebaert F, D'Amato T, Poulet E, Holtzmann J, Richieri RM, Attal J, Nieto I, El-Hage W, Bellivier F, Schmitt L, Lançon C, Bougerol T, Leboyer M, Aouizerate B, Haffen E, Courtet P, Llorca PM. Adherence to treatment guidelines in clinical practice for using electroconvulsive therapy in major depressive episode. J Affect Disord 2020; 264:318-323. [PMID: 32056767 DOI: 10.1016/j.jad.2020.01.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/30/2019] [Revised: 12/20/2019] [Accepted: 01/03/2020] [Indexed: 12/24/2022]
Abstract
BACKGROUND ECT is the most effective treatment of major depressive episode (MDE) but remains a neglected treatment. The French Society for Biological Psychiatry and Neuropsychopharmacology aimed to determine whether prescribing practice of ECT followed guidelines recommendations. METHODS This multicenter, retrospective study included adult patients with major depressive disorder (MDD) or bipolar disorder (BD), who have been treated with ECT for MDE. Duration of MDE and number of lines of treatment received before ECT were collected. The reasons for using ECT, specifically first-line indications (suicidality, urgency, presence of catatonic and psychotic features, previous ECT response, patient preference) were recorded. Statistical comparisons between groups used standard statistical tests. RESULTS Seven hundred and forty-five individuals were included. The mean duration of MDE before ECT was 10.1 months and the mean number of lines of treatment before ECT was 3.4. It was significantly longer for MDD single episode than recurrent MDD and BD. The presence of first-line indications for using ECT was significantly associated to shorter duration of MDE (9.1 vs 13.1 months, p<0.001) and lower number of lines of treatment before ECT (3.3 vs 4.1, p<0.001). LIMITATIONS This is a retrospective study and not all facilities practicing ECT participated that could limit the extrapolation of the results. CONCLUSION Compared to guidelines, ECT was not used as first-line strategy in clinical practice. The presence of first-line indications seemed to reduce the delay before ECT initiation. The improvements of knowledge and access of ECT are needed to decrease the gap between guidelines and clinical practice.
Collapse
Affiliation(s)
- L Samalin
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Department of Psychiatry, CHU Clermont-Ferrand, University of Clermont Auvergne, Clermont-Ferrand EA 7280, France.
| | - A Yrondi
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Service de Psychiatrie et de Psychologie Médicale de l'adulte, CHU de Toulouse, Hôpital Purpan, ToNIC Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, Toulouse, France
| | - T Charpeaud
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Department of Psychiatry, CHU Clermont-Ferrand, University of Clermont Auvergne, Clermont-Ferrand EA 7280, France
| | - J B Genty
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; University of Paris-Est, UMR_S955, UPEC, Créteil, France Inserm, U955, Equipe 15 Psychiatrie génétique, Créteil, France; AP-HP, Hôpital H. Mondor-A. Chenevier, Pôle de psychiatrie, Créteil, France
| | - O Blanc
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Department of Psychiatry, CHU Clermont-Ferrand, University of Clermont Auvergne, Clermont-Ferrand EA 7280, France
| | - A Sauvaget
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; CHU Nantes, Movement - Interactions - Performance, MIP, EA 4334, INSERM-U1246 SPHERE University of Nantes and University of Tours, Nantes, France
| | - F Stéphan
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Service Hospitalo-Universitaire de Psychiatrie Générale et de Réhabilitation Psycho Sociale, EA 7479, CHRU de Brest, Hôpital de Bohars, Brest, France
| | - M Walter
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Service Hospitalo-Universitaire de Psychiatrie Générale et de Réhabilitation Psycho Sociale, EA 7479, CHRU de Brest, Hôpital de Bohars, Brest, France
| | - D Bennabi
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Department of Clinical Psychiatry, CIC-1431 INSERM, CHU de Besançon, EA481 Neurosciences, University Bourgogne Franche-Comté, Besançon, France
| | - S Bulteau
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; CHU Nantes, Movement - Interactions - Performance, MIP, EA 4334, INSERM-U1246 SPHERE University of Nantes and University of Tours, Nantes, France
| | - F Haesebaert
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Centre Hospitalier Le Vinatier, Inserm U1028, CNRS UMR5292, Lyon Neuroscience Research Center, PSY-R2 Team, University Lyon 1, Lyon, France
| | - T D'Amato
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Centre Hospitalier Le Vinatier, Inserm U1028, CNRS UMR5292, Lyon Neuroscience Research Center, PSY-R2 Team, University Lyon 1, Lyon, France
| | - E Poulet
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Department of Emergency Psychiatry, hospices civils de Lyon, Edouard-Herriot Hospital, Neuroscience Research Center, CNRS UMR5292, PSY-R2 Team, University Lyon, Lyon, France
| | - J Holtzmann
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; CHU Grenoble Alpes, Grenoble Institut Neurosciences, Inserm, U1216, University of Grenoble Alpes, Grenoble, France
| | - R M Richieri
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Pôle Psychiatrie, CHU La Conception, Marseille, France
| | - J Attal
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; University Department of Adult Psychiatry, La Colombiere Hospital, CHU Montpellier, University of Montpellier 1, Inserm, Montpellier 1061, France
| | - I Nieto
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; AP-HP, GH Saint-Louis - Lariboisière - Fernand Widal, Pôle Neurosciences Tête et Cou, Inserm UMRS 1144, University Paris Diderot, Paris, France 16 UMR 1253, iBrain, University of Tours, Inserm, Tours, France
| | - W El-Hage
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Department of General and Academic Psychiatry, CH Charles Perrens, Bordeaux, Laboratory Nutrition and Integrative Neurobiology (UMR INRA 1286), University of Bordeaux, Bordeaux, France
| | - F Bellivier
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; AP-HP, GH Saint-Louis - Lariboisière - Fernand Widal, Pôle Neurosciences Tête et Cou, Inserm UMRS 1144, University Paris Diderot, Paris, France 16 UMR 1253, iBrain, University of Tours, Inserm, Tours, France
| | - L Schmitt
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Service de Psychiatrie et de Psychologie Médicale de l'adulte, CHU de Toulouse, Hôpital Purpan, ToNIC Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, Toulouse, France
| | - C Lançon
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Pôle Psychiatrie, CHU La Conception, Marseille, France
| | - T Bougerol
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; CHU Grenoble Alpes, Grenoble Institut Neurosciences, Inserm, U1216, University of Grenoble Alpes, Grenoble, France
| | - M Leboyer
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; University of Paris-Est, UMR_S955, UPEC, Créteil, France Inserm, U955, Equipe 15 Psychiatrie génétique, Créteil, France; AP-HP, Hôpital H. Mondor-A. Chenevier, Pôle de psychiatrie, Créteil, France
| | - B Aouizerate
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Department of General and Academic Psychiatry, CH Charles Perrens, Bordeaux, Laboratory Nutrition and Integrative Neurobiology (UMR INRA 1286), University of Bordeaux, Bordeaux, France
| | - E Haffen
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Department of Clinical Psychiatry, CIC-1431 INSERM, CHU de Besançon, EA481 Neurosciences, University Bourgogne Franche-Comté, Besançon, France
| | - P Courtet
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Department of Emergency Psychiatry and Acute Care, CHU Montpellier, Inserm U1061, Montpellier University, Montpellier, France
| | - P M Llorca
- French Society for Biological Psychiatry and Neuropsychopharmacology, Saint Germain en Laye, France; Fondation Fondamental, Créteil, France; Department of Psychiatry, CHU Clermont-Ferrand, University of Clermont Auvergne, Clermont-Ferrand EA 7280, France
| |
Collapse
|
13
|
Medina AL, Garcia A, Perez C, Montesinos P, Nieto I, Nieto A, Ochagavia V, Arias M, Salvador F, Salgado M, Muñoz V. EP-2024 Assessment of ADC value when comparing two methods to reduce geometrical distortion in DWMRI. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32444-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
14
|
Bennabi D, Yrondi A, Charpeaud T, Genty JB, Destouches S, Lancrenon S, Allaili N, Bellivier F, Bougerol T, Camus V, Doumy O, Dorey JM, Haesebaert F, Holtzmann J, Lançon C, Lefebvre M, Moliere F, Nieto I, Rabu C, Richieri R, Schmitt L, Stephan F, Vaiva G, Walter M, Leboyer M, El-Hage W, Aouizerate B, Haffen E, Llorca PM, Courtet P. Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental). BMC Psychiatry 2019; 19:50. [PMID: 30700272 PMCID: PMC6354367 DOI: 10.1186/s12888-019-2025-7] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/07/2018] [Accepted: 01/11/2019] [Indexed: 12/28/2022] Open
Abstract
BACKGROUND Recommendations for pharmacological treatments of major depression with specific comorbid psychiatric conditions are lacking. METHOD The French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental developed expert consensus guidelines for the management of depression based on the RAND/UCLA Appropriatneness Method. Recommendations for lines of treatment are provided by the scientific committee after data analysis and interpretation of the results of a survey of 36 psychiatrist experts in the field of major depression and its treatments. RESULTS The expert guidelines combine scientific evidence and expert clinician's opinion to produce recommendations for major depression with comorbid anxiety disorders, personality disorders or substance use disorders and in geriatric depression. CONCLUSION These guidelines provide direction addressing common clinical dilemmas that arise in the pharmacologic treatment of major depression with comorbid psychiatric conditions.
Collapse
Affiliation(s)
- D. Bennabi
- Service de Psychiatrie clinique, Centre Expert Dépression Résistante FondaMental, Centre Investigation Clinique 1431-INSERM, EA 481 Neurosciences, Université de Bourgogne Franche Comté, 25030 Besançon, France
| | - A. Yrondi
- Service de Psychiatrie et de Psychologie Médicale de l’adulte, Centre Expert Dépression Résistante FondaMental, CHRU de Toulouse, Hospital Purpan, ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France
| | - T. Charpeaud
- Service de Psychiatrie de l’adulte B, Centre Expert Dépression Résistante FondaMental, CHU de Clermont-Ferrand, Clermont-Ferrand, France
| | - J.-B. Genty
- SYLIA-STAT, 10, boulevard du Maréchal-Joffre, 92340 Bourg-la-Reine, France
| | - S. Destouches
- SYLIA-STAT, 10, boulevard du Maréchal-Joffre, 92340 Bourg-la-Reine, France
| | - S. Lancrenon
- SYLIA-STAT, 10, boulevard du Maréchal-Joffre, 92340 Bourg-la-Reine, France
| | - N. Allaili
- Service de Psychiatrie adulte, Centre Expert Dépression Résistante FondaMental, Hôpital Fernand-Widal, Paris, France
| | - F. Bellivier
- Service de Psychiatrie adulte, Centre Expert Dépression Résistante FondaMental, Hôpital Fernand-Widal, Paris, France
| | - T. Bougerol
- Service de Psychiatrie de l’adulte, CS 10217, Centre Expert Dépression Résistante FondaMental, CHU de Grenoble, Hôpital Nord, Grenoble, France
| | - V. Camus
- Clinique Psychiatrique Universitaire, Centre Expert Dépression Résistante FondaMental, CHRU de Tours, Université de Tours, Inserm U1253 imaging and Brain: iBrain, Tours, France
| | - O. Doumy
- Pôle de Psychiatrie Générale et Universitaire, Centre Expert Dépression Résistante FondaMental, CH Charles Perrens, UMR INRA 1286, NutriNeuro, Université de Bordeaux, Bordeaux, France
| | - J.-M. Dorey
- Old Age Psychiatry Unit, pôle EST, Centre Hospitalier le Vinatier, Bron, France
- Brain Dynamics and Cognition, Lyon Neuroscience Research Center, INSERM U1028, CNRS UMR 5292, Lyon, France
- Geriatrics Unit, CM2R, Hospices civils de Lyon, Hôpital des Charpennes, Villeurbanne, France
| | - F. Haesebaert
- Service universitaire des pathologies psychiatriques résistantes, Centre expert FondaMental, PSYR2 Team, Lyon Neuroscience Research Center, INSERM U1028, CNRS UMR5292, Centre Hospitalier Le Vinatier, University Lyon 1, Bron, France
| | - J. Holtzmann
- Service de Psychiatrie de l’adulte, CS 10217, Centre Expert Dépression Résistante FondaMental, CHU de Grenoble, Hôpital Nord, Grenoble, France
| | - C. Lançon
- Pôle Psychiatrie, Centre Expert Dépression Résistante FondaMental, CHU La Conception, Marseille, France
| | - M. Lefebvre
- Service universitaire des pathologies psychiatriques résistantes, Centre expert FondaMental, PSYR2 Team, Lyon Neuroscience Research Center, INSERM U1028, CNRS UMR5292, Centre Hospitalier Le Vinatier, University Lyon 1, Bron, France
| | - F. Moliere
- Département des Urgences et Post-Urgences Psychiatriques, Centre Expert Dépression Résistante FondaMental, CHU Montpellier, Univ Montpellier, Montpellier, France
| | - I. Nieto
- Service de Psychiatrie adulte, Centre Expert Dépression Résistante FondaMental, Hôpital Fernand-Widal, Paris, France
| | - C. Rabu
- DHU PePSY, Pole de psychiatrie et d’addictologie des Hôpitaux Universitaires Henri Mondor, Université Paris Est Créteil, Créteil, France
| | - R. Richieri
- Pôle Psychiatrie, Centre Expert Dépression Résistante FondaMental, CHU La Conception, Marseille, France
| | - L. Schmitt
- Service de Psychiatrie et de Psychologie Médicale de l’adulte, Centre Expert Dépression Résistante FondaMental, CHRU de Toulouse, Hospital Purpan, ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France
| | - F. Stephan
- Service hospitalo-universitaire de psychiatrie d’adultes et de psychiatrie de liaison - secteur 1, Centre Expert Dépression Résistante Fondamental, CHRU Brest, hôpital de Bohars, Bohars, France
| | - G. Vaiva
- Service de Psychiatrie adulte, Centre Expert Dépression Résistante FondaMental, CHU de Lille, Hôpital Fontan 1, Lille, France
| | - M. Walter
- Service hospitalo-universitaire de psychiatrie d’adultes et de psychiatrie de liaison - secteur 1, Centre Expert Dépression Résistante Fondamental, CHRU Brest, hôpital de Bohars, Bohars, France
| | - M. Leboyer
- DHU PePSY, Pole de psychiatrie et d’addictologie des Hôpitaux Universitaires Henri Mondor, Université Paris Est Créteil, Créteil, France
| | - W. El-Hage
- Clinique Psychiatrique Universitaire, Centre Expert Dépression Résistante FondaMental, CHRU de Tours, Université de Tours, Inserm U1253 imaging and Brain: iBrain, Tours, France
| | - B. Aouizerate
- Pôle de Psychiatrie Générale et Universitaire, Centre Expert Dépression Résistante FondaMental, CH Charles Perrens, UMR INRA 1286, NutriNeuro, Université de Bordeaux, Bordeaux, France
| | - E. Haffen
- Service de Psychiatrie clinique, Centre Expert Dépression Résistante FondaMental, Centre Investigation Clinique 1431-INSERM, EA 481 Neurosciences, Université de Bourgogne Franche Comté, 25030 Besançon, France
| | - P.-M. Llorca
- Service de Psychiatrie de l’adulte B, Centre Expert Dépression Résistante FondaMental, CHU de Clermont-Ferrand, Clermont-Ferrand, France
| | - P. Courtet
- Département des Urgences et Post-Urgences Psychiatriques, Centre Expert Dépression Résistante FondaMental, CHU Montpellier, Univ Montpellier, Montpellier, France
| |
Collapse
|
15
|
Charpeaud T, Genty JB, Destouches S, Yrondi A, Lancrenon S, Alaïli N, Bellivier F, Bennabi D, Bougerol T, Camus V, D'amato T, Doumy O, Haesebaert F, Holtzmann J, Lançon C, Lefebvre M, Moliere F, Nieto I, Richieri R, Schmitt L, Stephan F, Vaiva G, Walter M, Leboyer M, El-Hage W, Haffen E, Llorca PM, Courtet P, Aouizerate B. [French Society for Biological Psychiatry and Neuropsychopharmacology and Fondation FondaMental task force: Formal Consensus for the management of treatment-resistant depression]. Encephale 2018; 43:S1-S24. [PMID: 28822460 DOI: 10.1016/s0013-7006(17)30155-0] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Major depression represents among the most frequent psychiatric disorders in the general population with an estimated lifetime prevalence of 16-17%. It is characterized by high levels of comorbidities with other psychiatric conditions or somatic diseases as well as a recurrent or chronic course in 50 to 80% of the cases leading to negative repercussions on the daily functioning, with an impaired quality of life, and to severe direct/indirect costs. Large cohort studies have supported that failure of a first-line antidepressant treatment is observed in more than 60% of patients. In this case, several treatment strategies have been proposed by classical evidence-based guidelines from internationally recognized scientific societies, referring primarily on: I) the switch to another antidepressant of the same or different class; II) the combination with another antidepressant of complementary pharmacological profile; III) the addition of a wide range of pharmacological agents intending to potentiate the therapeutic effects of the ongoing antidepressant medication; IV) the association with appropriate psychological therapies; and, V) the use of non-invasive brain stimulation techniques. However, although based on the most recently available data and rigorous methodology, standard guidelines have the significant disadvantage of not covering a large variety of clinical conditions, while currently observed in everyday clinical practice. From these considerations, formalized recommendations by a large panel of French experts in the management of depressed patients have been developed under the shared sponsorship of the French Association of Biological Psychiatry and Neuropsychopharmacology (AFPBN) and the Fondation FondaMental. These French recommendations are presented in this special issue in order to provide relevant information about the treatment choices to make, depending particularly on the clinical response to previous treatment lines or the complexity of clinical situations (clinical features, specific populations, psychiatric comorbidities, etc.). Thus, the present approach will be especially helpful for the clinicians enabling to substantially facilitate and guide their clinical decision when confronted to difficult-to-treat forms of major depression in the daily clinical practice. This will be expected to significantly improve the poor prognosis of the treatment-resistant depression thereby lowering the clinical, functional and costly impact owing directly to the disease.
Collapse
Affiliation(s)
- T Charpeaud
- CHU de Clermont-Ferrand, centre expert dépression résistante FondaMental, service de psychiatrie de l'adulte B, 63003 Clermont-Ferrand, France.
| | - J-B Genty
- CHU de Clermont-Ferrand, centre expert dépression résistante FondaMental, service de psychiatrie de l'adulte B, 63003 Clermont-Ferrand, France
| | - S Destouches
- SYLIA-STAT, 10, boulevard du Maréchal-Joffre, 92340 Bourg-la-Reine, France
| | - A Yrondi
- CHRU de Toulouse, hôpital Purpan, centre expert dépression résistante FondaMental, service de psychiatrie de l'adulte, 31059 Toulouse, France
| | - S Lancrenon
- SYLIA-STAT, 10, boulevard du Maréchal-Joffre, 92340 Bourg-la-Reine, France
| | - N Alaïli
- Hôpital Fernand-Widal, centre expert dépression résistante FondaMental, service de psychiatrie adulte, 75010 Paris, France
| | - F Bellivier
- Hôpital Fernand-Widal, centre expert dépression résistante FondaMental, service de psychiatrie adulte, 75010 Paris, France
| | - D Bennabi
- CHU de Besançon, centre expert dépression résistante FondaMental, service de psychiatrie de l'adulte, 25030 Besançon Cedex, France
| | - T Bougerol
- CHU de Grenoble, hôpital nord, centre expert dépression résistante FondaMental, service de psychiatrie de l'adulte, CS 10217, 38043 Grenoble Cedex 9, France
| | - V Camus
- CHU de Tours, clinique psychiatrique universitaire, centre expert dépression résistante FondaMental, 37044 Tours Cedex 9, France
| | - T D'amato
- Centre hospitalier Le Vinatier, centre expert dépression résistante FondaMental, service universitaire de psychiatrie adulte, BP 300 39, 69678 Bron Cedex, France
| | - O Doumy
- CH Charles-Perrens, pôle de psychiatrie générale et universitaire, centre expert dépression résistante FondaMental, 33076 Bordeaux Cedex, France
| | - F Haesebaert
- Centre hospitalier Le Vinatier, centre expert dépression résistante FondaMental, service universitaire de psychiatrie adulte, BP 300 39, 69678 Bron Cedex, France
| | - J Holtzmann
- CHU de Grenoble, hôpital nord, centre expert dépression résistante FondaMental, service de psychiatrie de l'adulte, CS 10217, 38043 Grenoble Cedex 9, France
| | - C Lançon
- CHU La Conception, pôle psychiatrie centre, centre expert dépression résistante FondaMental, 13005 Marseille, France
| | - M Lefebvre
- Centre hospitalier Le Vinatier, centre expert dépression résistante FondaMental, service universitaire de psychiatrie adulte, BP 300 39, 69678 Bron Cedex, France
| | - F Moliere
- CHRU Lapeyronie, centre expert dépression résistante FondaMental, département des urgences et post-urgences psychiatriques, 34295 Montpellier Cedex 5, France
| | - I Nieto
- Hôpital Fernand-Widal, centre expert dépression résistante FondaMental, service de psychiatrie adulte, 75010 Paris, France
| | - R Richieri
- Centre hospitalier Le Vinatier, centre expert dépression résistante FondaMental, service universitaire de psychiatrie adulte, BP 300 39, 69678 Bron Cedex, France
| | - L Schmitt
- CHRU de Toulouse, hôpital Purpan, centre expert dépression résistante FondaMental, service de psychiatrie de l'adulte, 31059 Toulouse, France
| | - F Stephan
- CHU de Brest, hôpital de Bohars, centre expert dépression résistante FondaMental, service de psychiatrie de l'adulte, 29820 Bohars, France
| | - G Vaiva
- CHRU de Lille, hôpital Fontan 1, centre expert dépression résistante FondaMental, service de psychiatrie adulte, 59037 Lille Cedex, France
| | - M Walter
- CHU de Brest, hôpital de Bohars, centre expert dépression résistante FondaMental, service de psychiatrie de l'adulte, 29820 Bohars, France
| | - M Leboyer
- Hôpital Chenevier-Henri-Mondor, pôle de psychiatrie des hôpitaux universitaires, centre expert dépression résistante FondaMental, 94000 Créteil, France
| | - W El-Hage
- CHU de Tours, clinique psychiatrique universitaire, centre expert dépression résistante FondaMental, 37044 Tours Cedex 9, France
| | - E Haffen
- CHU de Besançon, centre expert dépression résistante FondaMental, service de psychiatrie de l'adulte, 25030 Besançon Cedex, France
| | - P-M Llorca
- CHU de Clermont-Ferrand, centre expert dépression résistante FondaMental, service de psychiatrie de l'adulte B, 63003 Clermont-Ferrand, France
| | - P Courtet
- CHRU Lapeyronie, centre expert dépression résistante FondaMental, département des urgences et post-urgences psychiatriques, 34295 Montpellier Cedex 5, France
| | - B Aouizerate
- CH Charles-Perrens, pôle de psychiatrie générale et universitaire, centre expert dépression résistante FondaMental, 33076 Bordeaux Cedex, France
| |
Collapse
|
16
|
Lopez Medina A, Reigosa S, Del Olmo J, Aramburu Nunez D, Salvador F, Landesa I, Alba J, Salgado M, Nieto I, Ochagavia V, Muñoz V. EP-1870: Improving Tumor Response Assessment using DWMRI corrected by reversed gradient method and DCEMRI. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)33121-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Nieto I, Gonzalez A, Ochagavia V. EP-1409: Neuropathic pain a secondary-effect in Classic Kaposi Sarcoma patients treated witth radiotherapy. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32659-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
18
|
Aramburu Nuñez D, Del Olmo Claudio J, Lopez Medina A, Mera Iglesias M, Salvador F, Ochagavia V, Nieto I, Del Moral F, Calzado A, Muñoz V. PO-0952: Multimodality functional imaging for biologically guided radiation therapy. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40944-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
19
|
Mera M, Aramburu D, Del Olmo J, Lopez Medina A, Salvador F, Nieto I, Ochagavia V, Landesa I, Alba J, Muñoz V. EP-1540: Validation of ARTFiBio registation software. Comparative with comercial software and shared datasets. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41532-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
20
|
Bennabi D, Aouizerate B, El-Hage W, Doumy O, Moliere F, Courtet P, Nieto I, Bellivier F, Bubrovsky M, Vaiva G, Holztmann J, Bougerol T, Richieri R, Lancon C, Camus V, Saba G, Haesbaert F, d'Amato T, Charpeaud T, Llorca PM, Leboyer M, Haffen E. Risk factors for treatment resistance in unipolar depression: a systematic review. J Affect Disord 2015; 171:137-41. [PMID: 25305428 DOI: 10.1016/j.jad.2014.09.020] [Citation(s) in RCA: 81] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/21/2014] [Revised: 09/14/2014] [Accepted: 09/18/2014] [Indexed: 12/28/2022]
Abstract
BACKGROUND Treatment resistant depression is a complex disorder and an important source of morbidity and mortality. Identification of risk factors of resistance may be useful to improve early recognition as well as treatment selection and prediction of outcome in patients with depression. METHODS The aim of this paper was to review the current status of knowledge regarding risk factors of treatment resistance in unipolar depression, in patients who failed to respond to at least two successive and adequate antidepressant treatments. RESULTS Systematic literature search yielded 8 publications exploring clinical and biological factors. Specific psychiatric comorbidities, psychosocial factors, clinical characteristics of the depressive episode and biological markers emerge as possible risk factor for treatment resistant depression. LIMITATIONS Due to the lack of objective definition and diagnostic criteria for treatment resistant depression, and the paucity of reports on risk factors, our review only summarized a small number of studies. CONCLUSION Future investigations of risk factors should help to improve the understanding of the mechanisms underlying resistance in mood disorders and contribute to improve their therapeutic management.
Collapse
Affiliation(s)
- D Bennabi
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France.
| | - B Aouizerate
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - W El-Hage
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - O Doumy
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - F Moliere
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - P Courtet
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - I Nieto
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - F Bellivier
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - M Bubrovsky
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - G Vaiva
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - J Holztmann
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - T Bougerol
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - R Richieri
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - C Lancon
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - V Camus
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - G Saba
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - F Haesbaert
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - T d'Amato
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - T Charpeaud
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - P M Llorca
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - M Leboyer
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| | - E Haffen
- Network of centres for Treatment-Resistant Depression, FondaMental Foundation, Créteil 94000, France
| |
Collapse
|
21
|
del Toro MD, Nieto I, Guerrero F, Corzo J, del Arco A, Palomino J, Nuño E, Lomas JM, Natera C, Fajardo JM, Delgado J, Torres-Tortosa M, Romero A, Martín-Rico P, Muniain MÁ, Rodríguez-Baño J. Are hip hemiarthroplasty and total hip arthroplasty infections different entities? The importance of hip fractures. Eur J Clin Microbiol Infect Dis 2014; 33:1439-48. [PMID: 24671411 DOI: 10.1007/s10096-014-2091-1] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2013] [Accepted: 03/09/2014] [Indexed: 01/21/2023]
Abstract
Hip hemiarthroplasty (HHA) and total hip arthroplasty (THA) infections are usually considered as one entity; however, they may show important differences. We analyze these differences, as well as predictors of treatment failure (TF) and poor functional status among patients with prosthetic hip infections (PHIs). A multicenter cohort study of consecutive patients with PHIs was performed. The main outcome variable was TF after the first surgical treatment performed to treat the infection. Multivariate analysis was used to identify predictors of TF. A total of 127 patients with PHI were included (43 HHA, 84 THA). Patients with HHA infections were more frequently women (88% vs. 54%; p < 0.001), had comorbidities (86% vs. 67%, p = 0.02), and were older (median age 79 vs. 65 years, p < 0.001), and the reason for arthroplasty was more frequently a fracture (100% vs. 18%, p < 0.001). Failure of initial treatment and crude mortality were more frequent among HHA patients (44% vs. 23%, p = 0.01 and 28% vs. 7%, p = 0.001, respectively). However, HHA was not associated with TF in the multivariate analysis when hip fracture was considered; thus, variables independently associated with TF were hip fracture, inadequate surgical management, prosthesis retention, and higher C-reactive protein level. Failure of the first surgical treatment was associated with poorer functional status. HHA and THA infections showed significant differences in epidemiology, clinical features, and outcome. Although patients with HHA infections had a higher risk of TF, this was related to the reason for hip implant: a hip fracture. Success of the initial management of infection is a predictor of better clinical and functional outcome.
Collapse
Affiliation(s)
- M D del Toro
- Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Avda. Dr. Fedriani 3, 41009, Sevilla, Spain,
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Martínez Díaz-Caneja C, Piqueras R, Nieto I, Pina-Camacho L, Janssen J, Merchán-Naranjo J, Fraguas D, De la Serna E, Baeza I, Castro-Fornieles J, Arango C. EPA-0863 - Progression of changes in brain structure and executive functions in children and adolescents with first-episode psychosis. Eur Psychiatry 2014. [DOI: 10.1016/s0924-9338(14)78194-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
23
|
Lopez Medina A, Aramburu D, Mera M, Del Olmo J, Andrade B, Ochagavia V, Nieto I, Salgado M, Calzado A, Munoz V. PD-0359: Tumour response: A multiparametric function. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)30464-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
24
|
Boudebesse C, Lajnef M, Geoffroy PA, Bellivier F, Nieto I, Gard S, Olié E, Azorin JM, Kahn JP, Bougerol T, Passerieux C, Aubin V, Milhiet V, Folkard S, Leboyer M, Henry C, Etain B. Chronotypes of Bipolar Patients in Remission: Validation of the French Version of the Circadian Type Inventory in the FACE-BD Sample. Chronobiol Int 2013; 30:1042-9. [DOI: 10.3109/07420528.2013.798330] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
25
|
Triñanes Perez A, Medina Fana M, Nieto I, Ochagavia V, Martinez Agra M, Willisch Santamaria P, Leiva Urbina R, Muñoz Garzon V. Ewing sarcoma: Long-survivor. Rep Pract Oncol Radiother 2013. [DOI: 10.1016/j.rpor.2013.03.155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
26
|
Triñanes Perez A, Nieto I, Ochagavia V, Medina Fana M, Leiva Urbina R, Willisch Santamaria P, Martinez Agra M, Muñoz Garzon V. Pediatric neuroblastoma: Long-survivor. Rep Pract Oncol Radiother 2013. [DOI: 10.1016/j.rpor.2013.03.168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
27
|
Lopez Medina A, Aramburu D, Mera M, Pereira L, Landesa I, Ochagavia V, Nieto I, Mañas J, Nogueiras J, Muñoz V. PO-0860: ARTFIBio Project: quantifying tumour response voxel by voxel. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33166-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
28
|
Nicoli M, Bouchez S, Nieto I, Gasquet I, Kovess V, Lépine JP. Idéation et conduites suicidaires en France : prévalence sur la vie et facteurs de risque dans l’étude ESEMeD. Encephale 2012; 38:296-303. [DOI: 10.1016/j.encep.2011.02.006] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2010] [Accepted: 12/09/2010] [Indexed: 10/17/2022]
|
29
|
Schuenemann G, Nieto I, Bas S, Galvão K, Workman J. Erratum to “Assessment of calving progress and reference times for obstetric intervention during dystocia in Holstein dairy cows” (J. Dairy Sci. 94:5494–5501). J Dairy Sci 2012. [DOI: 10.3168/jds.2012-95-1-497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
30
|
Schuenemann G, Nieto I, Bas S, Galvão K, Workman J. Assessment of calving progress and reference times for obstetric intervention during dystocia in Holstein dairy cows. J Dairy Sci 2011; 94:5494-501. [DOI: 10.3168/jds.2011-4436] [Citation(s) in RCA: 96] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2011] [Accepted: 07/10/2011] [Indexed: 11/19/2022]
|
31
|
Sanabria M, Muñoz J, Trillos C, Hernández G, Latorre C, Díaz CS, Murad S, Rodríguez K, Rivera A, Amador A, Ardila F, Caicedo A, Camargo D, Díaz A, González J, Leguizamón H, Lopera P, Marín L, Nieto I, Vargas E. Dialysis outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia. Kidney Int 2008:S165-72. [PMID: 18379541 DOI: 10.1038/sj.ki.5002619] [Citation(s) in RCA: 69] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
The goal of the Dialysis Outcomes in Colombia (DOC) study was to compare the survival of patients on hemodialysis (HD) vs peritoneal dialysis (PD) in a network of renal units in Colombia. The DOC study examined a historical cohort of incident patients starting dialysis therapy between 1 January 2001 and 1 December 2003 and followed until 1 December 2005, measuring demographic, socioeconomic, and clinical variables. Only patients older than 18 years were included. As-treated and intention-to-treat statistical analyses were performed using the Kaplan-Meier method and Cox proportional hazard model. There were 1094 eligible patients in total and 923 were actually enrolled: 47.3% started HD therapy and 52.7% started PD therapy. Of the patients studied, 751 (81.3%) remained in their initial therapy until the end of the follow-up period, death, or censorship. Age, sex, weight, height, body mass index, creatinine, calcium, and Subjective Global Assessment (SGA) variables did not show statistically significant differences between the two treatment groups. Diabetes, socioeconomic level, educational level, phosphorus, Charlson Co-morbidity Index, and cardiovascular history did show a difference, and were less favorable for patients on PD. Residual renal function was greater for PD patients. Also, there were differences in the median survival time between groups: 27.2 months for PD vs 23.1 months for HD (P=0.001) by the intention-to-treat approach; and 24.5 months for PD vs 16.7 months for HD (P<0.001) by the as-treated approach. When performing univariate Cox analyses using the intention-to-treat approach, associations were with age > or =65 years (hazard ratio (HR)=2.21; confidence interval (CI) 95% (1.77-2.755); P<0.001); history of cardiovascular disease (HR=1.96; CI 95% (1.58-2.90); P<0.001); diabetes (HR=2.34; CI 95% (1.88-2.90); P<0.001); and SGA (mild or moderate-severe malnutrition) (HR=1.47; CI 95% (1.17-1.79); P=0.001); but no association was found with gender (HR=1.03, CI 95% 0.83-1.27; P=0.786). Similar results were found with the as-treated approach, with additional associations found with Charlson Index (0-2) (HR=0.29; Cl 95% (0.22-0.38); P<0.001); Charlson Index (3-4) (HR=0.61; Cl 95% (0.48-0.79); P<0.001); and SGA (mild-severe malnutrition) (HR=1.43; Cl 95% (1.15-1.77); P<0.001). Similarly, the multivariate Cox model was run with the variables that had shown association in previous analyses, and it was found that the variables explaining the survival of patients with end-stage renal disease in our study were age, SGA, Charlson Comorbidity Index 5 and above, diabetes, healthcare regimes I and II, and socioeconomic level 2. The results of Cox proportional risk model in both the as-treated and intention-to-treat analyses showed that there were no statistically significant differences in survival of PD and HD patients: intention-to-treat HD/PD (HR 1.127; CI 95%: 0.855-1.484) and as-treated HD/PD (HR 1.231; CI 95%: 0.976-1.553). In this historical cohort of incident patients, there was a trend, although not statistically significant, for a higher (12.7%) adjusted mortality risk associated with HD when compared to PD, even though the PD patients were poorer, were more likely to be diabetic, and had higher co-morbidity scores than the HD patients. The variables that most influenced survival were age, diabetes, comorbidity, healthcare regime, socioeconomic level, nutrition, and education.
Collapse
Affiliation(s)
- M Sanabria
- Baxter - RTS Colombia, Bogotá, Colombia.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
García-Tejero P, García-Frasquet M, Borrás A, Carpintero R, Nieto I. La densitometría de calcáneo permite discriminar fracturas de muñeca en mujeres ancianas. ACTA ACUST UNITED AC 2007. [DOI: 10.1016/s0482-5985(07)75552-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
33
|
Carpintero M, Nieto I, Fernández-Mayoralas A. Stereospecific synthesis of alpha- and beta-C-glycosides from glycosyl sulfoxides: scope and limitations. J Org Chem 2001; 66:1768-74. [PMID: 11262125 DOI: 10.1021/jo0014515] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
C-Glycosides derived from alpha-L-fuco-, alpha-D-gluco-, beta-D-gluco-, and alpha-D-mannopyranose have been synthesized from the corresponding glycosyl phenyl sulfoxide through phenylsulfinyl-lithium exchange, to generate an anomeric carbanion, and subsequent reaction with a carbon electrophile. The reactions were stereospecific and proceeded with retention of the configuration at the anomeric center. Improved yields of C-glycosides were obtained by an inverse addition protocol. Trapping of the anomeric carbanion with aldehydes gave best results. Reaction with ketones, chloroformates, nitriles, and alkyl halides was also explored. Mechanistic aspects of the reaction are discussed.
Collapse
Affiliation(s)
- M Carpintero
- Instituto de Química Orgcinica General, CSIC, Juan de la Cierva 3, 28006 Madrid, Spain
| | | | | |
Collapse
|
34
|
Nieto I, Figueira MJ, Blanco JM, Caamaño O, Fernández F, De Clercq E, Balzarini J. Synthesis of novel carbocyclic nucleosides with a modified cyclopentane ring and evaluation of their antiviral activity. Nucleosides Nucleotides 1999; 18:641-2. [PMID: 10432656 DOI: 10.1080/15257779908041525] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
New carbocyclic nucleosides with purine (compounds 2a-2c), 8-azapurine (compounds 2d and 2e) or pyrimidine (compound 3) as base were prepared and assayed for in vitro activity.
Collapse
Affiliation(s)
- I Nieto
- Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago, Spain
| | | | | | | | | | | | | |
Collapse
|
35
|
Llach J, Bordas JM, Nieto I, Landaeta J, Elizalde JI, Mondelo F, Gines A, Salmeron JM, Mas A, Teres J, Rodes J. Endoscopic sclerotherapy to arrest uncontrolled variceal bleeding in cirrhotic patients with high surgical risk. Hepatogastroenterology 1998; 45:2181-5. [PMID: 9951890] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Abstract
BACKGROUND/AIMS In 20-50% of patients bleeding from esophageal varices, conservative procedures fail to obtain hemostasis and prevent early recurrence. METHODOLOGY We retrospectively analyzed the efficacy and safety of endoscopic sclerotherapy in 66 cirrhotic patients with high surgical risk and persistence or recurrence of variceal bleeding in spite of adequate medical treatment (somatostatin and/or balloon tamponade). RESULTS Emergency sclerosis controlled bleeding in 46 out of 66 patients (70%). The remaining 20 patients underwent additional procedures to arrest the hemorrhage, and 6 died because of massive bleeding. Early rebleeding occurred in 5 patients (10%). The mortality within 2 days, 1 week, and 6 weeks was 9%, 17% and 32%, respectively. Death was attributed to hemorrhage in 9 cases. Sclerotherapy was associated with complications in 9 patients (14%). CONCLUSION These results suggest that emergency sclerotherapy is a safe and effective procedure in cirrhotic patients with high surgical risk and persistence or recurrence of bleeding after conservative hemostatic procedures.
Collapse
Affiliation(s)
- J Llach
- Gastroenterology Department, Institut Clinic de Malalties Digestives, University of Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Cuevas P, Carceller F, Nieto I, Giménez-Gallego G. Spasmolytic effect of acidic fibroblast growth factor in early cerebral vasospasm in the rat. Surg Neurol 1998; 49:176-9; discussion 179-80. [PMID: 9457268 DOI: 10.1016/s0090-3019(97)00167-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
BACKGROUND In animal models of subarachnoid hemorrhage (SAH), basilar artery spasm has been described. Since fibroblast growth factors (FGFs) dilate rat basilar artery in vivo, we tested whether systemic administration of acidic fibroblast growth factor (aFGF) can reverse the basilar artery spasm following rat SAH. METHODS SAH was mimicked by injecting autologous blood into the cisterna magna. We used a digital substraction angiography system in order to evaluate the spasmolytic effect of aFGF administered via the axillary artery 7 minutes after the injection of the autologous blood. Control animals received vehicle solution in the same manner. RESULTS Intraarterial bolus injection of 2.6 micrograms aFGF, but not the solvent, reverses the acute basilar artery narrowing caused by SAH (23.05% of the baseline value at 5 minutes post-SAH). CONCLUSIONS Our results suggest an important role for FGFs in the cerebral tone regulation and support a clinical interest of FGFs in preventing cerebral ischemia following SAH, particularly if these vasoactive effects are added to the known neuroprotective effects of FGFs.
Collapse
Affiliation(s)
- P Cuevas
- Servicio de Histología, Hospital Ramón y Cajal, Madrid, Spain
| | | | | | | |
Collapse
|
37
|
Abstract
A 31-year-old man, an intravenous drug user and in an advanced stage of acquired immune deficiency syndrome (AIDS), was admitted in our Department for the treatment of skin lesions that had been diagnosed as molluscum contagiosum (MC). The clinical examination revealed the presence of multiple nodular lesions, some of which were notably large and whose color resembled that of normal skin. These lesions were localized mainly to the face, and in particular on the forehead, glabellar, malar, beard, submandibular, and neck regions (Fig. 1). Smaller, crateriform lesions were detected on the hands and the upper limbs. The lymphocyte subsets ratio was 0.02, with a CD4+ T cell count of 13 cells per mm3 (1%) and a CD8+ T cell count of 624 per mm3 (48%). The patient also had leukopenia (1690 WBC per mm3), moderate macrocytic anemia, elevation of transaminases (SGOT 105 U/L, SGPT 114 U/L) and of immunoglobulins (IgG 2660 mg/dL), and a decrease of C3 (44.2 mg/dL) and C4 (16.6 mg/dL). Histologic examination revealed the presence of typical MC lesions. In addition to an important acanthosis, it was possible to detect pyriform lobules of perfectly delineated epidermal cells, radially separated by fibrous septa that merge towards the central crater. The characteristic MC eosinophil bodies were observed in infected cells (Fig. 2). The lesions were treated with cryosurgery by spray. Many courses of therapy were given with intervals of 2-3 weeks. Every session consisted of two cycles of rapid freezing followed by a slow thaw. Many lesions disappeared with this treatment, and others were reduced in size, but total destruction of all lesions was not achieved (Fig. 3).
Collapse
|
38
|
Nieto I, Llach J, Bordas JM, Mondelo F, Elizalde I, Bataller R, Terés J. [Endoscopic gastrointestinal findings in patients with human immunodeficiency virus infection]. Gastroenterol Hepatol 1995; 18:57-60. [PMID: 7621275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
From January 1992 to August 1993, 150 endoscopies (114 fiber gastroscopies, 29 fiber colonoscopies and 7 CPRE) were carried out in a total of 142 anti HIV positive patients. The most frequent clinical manifestations leading to the exploration were dysphagia, epigastric pain, diarrhea and upper or lower gastrointestinal bleeding. Endoscopic alterations were observed in most of the exploration although specific diagnosis was only achieved in approximately one third of the patients with the most frequent being esophagitis by Candida and CMV (21% and 5%, respectively in the fiber gastroscopies performed). Digestive manifestations were varied in the patients in whom esophagitis by Candida was diagnosed while dysphagia and diarrhea were the symptoms commonly observed in the patients with esophagitis or colitis by CMV. The diagnostic profitability of endoscopy was high in patients presenting dysphagia, diarrhea, gastrointestinal bleeding or in those in whom endoscopy was performed for tumoral staging or to evaluate the possible existence of manifestations secondary to the presence of portal hypertension.
Collapse
Affiliation(s)
- I Nieto
- Servicios de Gastroenterología, Hospital Clínic i Provincial, Barcelona
| | | | | | | | | | | | | |
Collapse
|
39
|
Abstract
Acidic and basic fibroblast growth factors (FGFs) are members of a family of proteins that are broad-spectrum mitogens, have diverse hormone-like activities, and function in tumorigenesis. FGF's ability to raise the concentration of intracellular calcium ion suggests that FGF could induce the synthesis of endothelium-derived relaxing factor (EDRF) and consequently vasodilation. Systemic administration of FGF decreased arterial blood pressure. This effect was mediated by EDRF and by adenosine triphosphate-sensitive potassium ion channels. The hypotensive effect of FGF was segregated from its mitogenic activity by protein engineering. These results extend the range of FGF autocrine activities and potential therapeutic applications, emphasize the role of endothelium as an arterial blood pressure--regulating organ, and provide insight on the structural basis of FGF functions.
Collapse
Affiliation(s)
- P Cuevas
- Hospital Universitario Ramón y Cajal, Carretera de Colmenar, Madrid, Spain
| | | | | | | | | | | |
Collapse
|
40
|
Borja Corcostegui F, Nieto I, Garcia-Arumi J. [Early retinal capillary hemangiomas. Study of 7 tumors]. Ophtalmologie 1988; 2:271-4. [PMID: 3247187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
41
|
Soto M, Gómez Montoya J, Heredero J, Nieto I. [Intracranial epidermoids. Cooperative study]. Arch Neurobiol (Madr) 1984; 47:119-42. [PMID: 6508477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|